Back to Search
Start Over
NRx Pharmaceuticals Produces First Phase 3-stage NRX-101 Drug Made Using Commercial Process
- Source :
- Plus Company Updates. November 11, 2022
- Publication Year :
- 2022
-
Abstract
- RADNOR: NRx Pharmaceuticals, Inc. has issued the following news release: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), ('NRx Pharmaceuticals' or the 'Company'), a clinical-stage CNS biopharmaceutical company, today announced the release of [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.726476014